Illuminating Breast Cancer Recurrence Risk  |   > Search     |   Take me to: Genomic Health - Home Oncotype - Home Healthcare Professionals Patients and Caregivers Oncotype DX Logistics About Oncotype DX What is Oncotype DX? Who is Oncotype DX For? How is Oncotype DX Performed? How Can Oncotype DX Benefit Me? Oncotype DX Results How Do I Get a Test? About Recurrence Oncotype DX Development Health Insurance Coverage Frequently Asked Questions Glossary Helpful Links How Do I Get a Test? Oncotype DX® is a diagnostic test that can only be ordered by your authorized healthcare provider. It is a non-invasive test that is performed on a small amount of the tissue removed during your original surgery (lumpectomy, mastectomy, or core biopsy). This means you do not have to undergo any additional invasive procedures. Your authorized healthcare provider submits the tumor tissue sample to Genomic Health® for analysis. The results of the Oncotype DX assay are provided to your physician within 10 to 14 days from the date the tumor sample is sent to Genomic Health. Talk to your healthcare provider to determine if Oncotype DX is right for you. What's New? November 11, 2008 Genomic Health to Present at Stephens Fall Investment Conference November 10, 2008 Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated

© 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |